Sleep apnea and hypertension

Minerva Medica

Volumn 95, Issue 4, 2004, Pages 281-290

  Hoffmann, M ^a   Bybee, K ^a   Accurso, V ^a   Somers, V K ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apnea; Hypertension; Sleep

Indexed keywords

ADRENERGIC SYSTEM; BODY MASS; BREATHING DISORDER; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDER;

HUMANS; HYPERTENSION; SLEEP APNEA, OBSTRUCTIVE;

EID: 6344252807     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Sin DD, Fitzgerald F, Parker JD, Newton GE, Logan AG, Floras JS et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003;123:1536-43.
3. Ancoli-Israel S, DuHamel ER, Stepnowsky C, Engler R, Cohen-Zion M, Marier M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest 2003;124:1400-5.
4. Javaheri, S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-9.
5. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoën-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002;122:1133-8.
6. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160: 1101-6.
7. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
8. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996;27:252-9.
9. Wessendorf TE, Dahm C, Teschler H. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 2003;60:1053; author reply 1053.
10. Kaynak D, Goksan B, Kaynak H, Degirmenci N, Daglioglu S. Is there a link between the severity of sleep-disordered breathing and atherosclerotic disease of the carotid arteries? Eur J Neurol 2003;10:487-93.
11. Mooe T, Gullsby S, Rabben T, Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 1996;7:475-8.
12. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-94.
13. Coccagna G, Capucci A, Bauleo S, Boriani G, Santarelli A. Paroxysmal atrial fibrillation in sleep. Sleep 1997;20:396-8.
14. Silverberg DS, Oksenberg A. Essential hypertension and abnormal upper airway resistance during sleep. Sleep 1997;20:794-806.
15. Silverberg DS, Oksenberg A, Iana A. Sleep-related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed and undertreated. Am J Hypertens 1997;10:1319-25.
16. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
17. Vgontzas AN, Tan TL, Bixler E, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-11.
18. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000;283:1829-36.
19. Ohayon MM, Guilleminault C, Priest RG, Zulley J, Smirne S. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)? J Psychosom Res 2000;48:593-601.
20. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342: 1378-84.
21. Bixler EO, Vgontzas AN, Lin HN, Ten Have T, Leiby BE, Vela-Bueno A et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160: 2289-95.
22. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003;42:1007-74.
23. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001;19:2271-7.
24. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997;15:1227-33.
25. Davies CWH, Crosby JH, Mullins RL, Barbour C, Davies RJO, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736-40.
26. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993;328:303-7.
27. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
28. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998;98:772-6.
29. Carlson JT, Hedner JA, Seligren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:1490-6.
30. Parati G, Di Rienzo M, Bonsignore MR, Insalaco G, Marrone O, Castiglioni P et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997;15:1621-6.
31. Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE, Somers VK. Baroreflex control of sympathetic activity and heart rate in obstructive sleep apnea. Hypertension 1998;32:1039-43.
32. Parati G, Ongaro G, Bonsignore MR, Glavina F, Di Rienzo M, Mancia G. Sleep apnoea and hypertension. Curr Opin Nephrol Hypertens 2002;11:201-14.
33. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998;32:293-7.
34. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992;152:1855-60.
35. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993;11:1133-7.
36. Kannel WB, Kannel C, Paffenbarger RS. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987;113:1489-94.
37. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001;79:21-9.
38. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003;16:274-80.
39. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004;125:112-7.
40. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993; 16:S15-21.
41. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993;23:118-26.
42. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces Superoxide anion production by mesangial cells. Kidney Int 1998;54:775-84.
43. Hannken T, Schroeder R, Stahl RA, Wolf G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 1998;54: 1923-33.
44. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001;37:541-6.
45. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol 2003;284: R893-912.
46. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: Basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-6.
47. Somers MJ, Harrison DG. Reactive oxygen species and the control of vasomotor tone. Curr Hypertens Rep 1999;1:102-8.
48. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 2002;4:160-6.
49. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27: 123-8.
50. Hartmann G, Tschop M, Fischer R, Bidlingmaier C, Riepl R, Tschop K et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000;12:246-52.
51. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999;84:2603-7.
52. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-6.
53. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-4.
54. Lavie P. Pro: sleep apnea causes cardiovascular disease. Am J Respir Crit Care Med 2004;169:147-8.
55. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
56. Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-Amione G. The role of inflammation in the pathogenesis of heart failure. Curr Cardiol Rep 2002;4:200-5.
57. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J 1998;19:761-5.
58. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
59. Woollard KJ, Phillips DC, Griffiths HR. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 2002;130:256-62.
60. Kisilevsky R, Tam SP. Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease. Pediatr Pathol Mol Med 2002;21:291-305.
61. Svatikova A, Wolk R, Shamsuzzaman AS, Kara T, Olson EJ, Somers VK. Serum amyloid A in obstructive sleep apnea. Circulation 2003;108:1451-4.
62. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G et al. Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 1996;9:1186-91.
63. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001;14:1038-45.
64. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001;37:1523-8.
65. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-10.
66. Kraiczi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493-8.
67. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;109:348-53.
68. Phillips BG, Hisel TM, Kato M, Pesek CA, Dyken ME, Narkiewicz K et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999;17:1297-300.
69. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 2000;279:H234-7.
70. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999;100:706-12.
71. Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 2001;24:721-5.
72. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-8.
73. Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998;11(3 Pt 1): 272-9.
74. Grote L, Heitmann J, Kohler U, Ploch T, Penzel T, Peter JH. Effect of angiotensin converting enzyme inhibition [Cilazapril] on blood pressure recording in hypertensive obstructive sleep apneic patients. Blood Press 1997;6:235-41.
75. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004;43:518-24.
76. Schwanz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991;144:494-8.
77. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9.
78. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71.
79. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.